Login
Home
Charts
Search
Watchlist
Products

Gufic BioSciences Ltd

GUFICBIO·NSE
₹431.75-2.35%Wed, 23 Sept '26 13:17
Industry:Pharma - Formulators
Indices:

Gufic BioSciences Ltd

GUFICBIO
NSE
₹431.75
-2.35%
|Wed, 23 Sept '26 13:17
SOICxStockScans Reports
Industry
Pharma - Formulators
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹4,338Cr
Close
Close Price
₹432.55
Industry
Industry
Pharma - Formulators
PE
Price To Earnings
59.09
PS
Price To Sales
4.42
Revenue
Revenue
₹981Cr
Rev Gr TTM
Revenue Growth TTM
16.70%
PAT Gr TTM
PAT Growth TTM
18.72%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
215202195203204208205224237231252261
Growth YoY
Revenue Growth YoY%
-5.03.05.110.316.111.422.816.6
Expenses
ExpensesCr
176165161167166174179190199198205214
Operating Profit
Operating ProfitCr
393634363934263338334747
OPM
OPM%
18.318.117.617.618.916.312.914.916.014.318.817.9
Other Income
Other IncomeCr
0011020121-10
Interest Expense
Interest ExpenseCr
4345558910899
Depreciation
DepreciationCr
444445888888
PBT
PBTCr
313027282926111723182930
Tax
TaxCr
877777346578
PAT
PATCr
23222021221981317122222
Growth YoY
PAT Growth YoY%
-6.2-13.3-61.5-37.3-22.7-35.7183.770.7
NPM
NPM%
10.811.010.310.310.79.33.85.87.15.48.78.6
EPS
EPS₹
2.42.22.02.12.21.90.81.31.71.22.22.2
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
215202195203204208205224237231252261
Growth YoY
Revenue Growth YoY%
-5.03.05.110.316.111.422.816.6
Expenses
ExpensesCr
176165161167166174179190199198205214
Operating Profit
Operating ProfitCr
393634363934263338334747
OPM
OPM%
18.318.117.617.618.916.312.914.916.014.318.817.9
Other Income
Other IncomeCr
0011020121-10
Interest Expense
Interest ExpenseCr
4345558910899
Depreciation
DepreciationCr
444445888888
PBT
PBTCr
313027282926111723182930
Tax
TaxCr
877777346578
PAT
PATCr
23222021221981317122222
Growth YoY
PAT Growth YoY%
-6.2-13.3-61.5-37.3-22.7-35.7183.770.7
NPM
NPM%
10.811.010.310.310.79.33.85.87.15.48.78.6
EPS
EPS₹
2.42.22.02.12.21.90.81.31.71.22.22.2

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
807820944981
Growth
Revenue Growth%
1.615.216.7
Expenses
ExpensesCr
661684793816
Operating Profit
Operating ProfitCr
146136151165
OPM
OPM%
18.116.616.016.8
Other Income
Other IncomeCr
2432
Interest Expense
Interest ExpenseCr
15253737
Depreciation
DepreciationCr
17213131
PBT
PBTCr
116948799
Tax
TaxCr
30242226
PAT
PATCr
86706473
Growth
PAT Growth%
-19.1-7.818.7
NPM
NPM%
10.78.56.87.5
EPS
EPS₹
8.77.06.47.3
Financial YearMar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
807820944981
Growth
Revenue Growth%
1.615.216.7
Expenses
ExpensesCr
661684793816
Operating Profit
Operating ProfitCr
146136151165
OPM
OPM%
18.116.616.016.8
Other Income
Other IncomeCr
2432
Interest Expense
Interest ExpenseCr
15253737
Depreciation
DepreciationCr
17213131
PBT
PBTCr
116948799
Tax
TaxCr
30242226
PAT
PATCr
86706473
Growth
PAT Growth%
-19.1-7.818.7
NPM
NPM%
10.78.56.87.5
EPS
EPS₹
8.77.06.47.3

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
101010
Reserves
ReservesCr
523591655
Current Liabilities
Current LiabilitiesCr
372388518
Non Current Liabilities
Non Current LiabilitiesCr
188181160
Total Liabilities
Total LiabilitiesCr
1,0931,1691,342
Current Assets
Current AssetsCr
600625802
Non Current Assets
Non Current AssetsCr
492545540
Total Assets
Total AssetsCr
1,0931,1691,342
Financial YearMar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
101010
Reserves
ReservesCr
523591655
Current Liabilities
Current LiabilitiesCr
372388518
Non Current Liabilities
Non Current LiabilitiesCr
188181160
Total Liabilities
Total LiabilitiesCr
1,0931,1691,342
Current Assets
Current AssetsCr
600625802
Non Current Assets
Non Current AssetsCr
492545540
Total Assets
Total AssetsCr
1,0931,1691,342

Cash Flow

Consolidated
Standalone
Financial YearMar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-712345
Investing Cash Flow
Investing Cash FlowCr
-102-71-31
Financing Cash Flow
Financing Cash FlowCr
82-3732
Net Cash Flow
Net Cash FlowCr
-271546
Free Cash Flow
Free Cash FlowCr
-312745
CFO To PAT
CFO To PAT%
-8.7176.070.3
CFO To EBITDA
CFO To EBITDA%
-5.190.129.8
Financial YearMar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-712345
Investing Cash Flow
Investing Cash FlowCr
-102-71-31
Financing Cash Flow
Financing Cash FlowCr
82-3732
Net Cash Flow
Net Cash FlowCr
-271546
Free Cash Flow
Free Cash FlowCr
-312745
CFO To PAT
CFO To PAT%
-8.7176.070.3
CFO To EBITDA
CFO To EBITDA%
-5.190.129.8

Ratios

Consolidated
Standalone
Financial YearMar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,8393,3742,7534,338
Price To Earnings
Price To Earnings
33.048.442.959.1
Price To Sales
Price To Sales
3.54.12.94.4
Price To Book
Price To Book
5.35.64.16.5
EV To EBITDA
EV To EBITDA
21.627.120.428.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
45.948.547.147.1
OPM
OPM%
18.116.616.016.8
NPM
NPM%
10.78.56.87.5
ROCE
ROCE%
15.112.711.511.5
ROE
ROE%
16.211.69.79.7
ROA
ROA%
7.96.04.84.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,8393,3742,7534,338
Price To Earnings
Price To Earnings
33.048.442.959.1
Price To Sales
Price To Sales
3.54.12.94.4
Price To Book
Price To Book
5.35.64.16.5
EV To EBITDA
EV To EBITDA
21.627.120.428.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
45.948.547.147.1
OPM
OPM%
18.116.616.016.8
NPM
NPM%
10.78.56.87.5
ROCE
ROCE%
15.112.711.511.5
ROE
ROE%
16.211.69.79.7
ROA
ROA%
7.96.04.84.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Gufic BioSciences Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/no774lkz0567q2ylv5ngavy6.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/zafer7ksoalcnu41qrv5irky.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/2obpu1e6g0r1yrmdpdchigc8.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/ofomku1wi5kdktmxshpwhbco.pdf
  • Q1 FY2026 Earnings Call Transcript (Jun 2025, PDF): https://www.stockscans.in/document/jhdjcnphb5h2no7svqh42hmk.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/96vu5rdx0a6mbcrtyr006heq.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/4uvv1xanl8obt4jdl44gccsr.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/ha24pkbbzdrz6mi8fuzaszz0.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/p03ndqj2xam6wdggpwh9imc6.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/vjzjekzqzidp8pive00tmtyq.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/gxhi3nmm6mvucn1fhij32otz.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/6kd7c472sgwx87ey0twrst7g.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/kqbavifyosvwy85phkq26r48.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/ggrdpxsdqlrmff9lsn5zou5m.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/ljw0088ap5pd2m8nr6h3liwc.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/lbj98hvhsact4ongyudbz0a0.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/bgy1a8lfcb18y1i2haacn44e.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/pk1jajm65js0lgwotrrrmch5.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/7aslhx0wshgueb2h18ulu5ri.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/br2tiznwwcoxm4dt3v5sq7uc.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/srvfw0y0vq3q3nvzw9j86fdp.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/nfd6v1w1eqvkttpel1138rjg.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/3h4w36d5ks8n6eijjkrbd4it.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/h5fv3udi9sf5owa474bq4azw.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/q64jeqhk74accqdrchxko7cp.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/pm2mvxxwlqhjx2o0lnc1nd28.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/mtxuve8te7uv1hkk3z0ekyig.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/4udv7tywvrh86r6wye9dxebl.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/2v0o2sh8mqka8q3j1k8zcyvc.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/5r3p9296om1k5ycihy592lm2.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/496nmpeszwp1iys7zz73c02f.pdf

Concall Transcript Summaries — Gufic BioSciences Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3AGUFICBIO/transcript-notes/202606/no774lkz0567q2ylv5ngavy6.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3AGUFICBIO/transcript-notes/202603/zafer7ksoalcnu41qrv5irky.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3AGUFICBIO/transcript-notes/202512/2obpu1e6g0r1yrmdpdchigc8.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3AGUFICBIO/transcript-notes/202509/ofomku1wi5kdktmxshpwhbco.pdf
  • Q1 FY2026 Concall Transcript Summary (Jun 2025): https://www.stockscans.in/company/NSE%3AGUFICBIO/transcript-notes/202506/jhdjcnphb5h2no7svqh42hmk.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3AGUFICBIO/transcript-notes/202503/96vu5rdx0a6mbcrtyr006heq.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3AGUFICBIO/transcript-notes/202412/4uvv1xanl8obt4jdl44gccsr.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3AGUFICBIO/transcript-notes/202409/ha24pkbbzdrz6mi8fuzaszz0.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies